Neoadjuvant hyperthermic intraperitoneal chemotherapy: impact on chemotherapy response score and prognosis in high-grade serous ovarian carcinoma
This study supports the notion that the treatment regimen of NHIPEC combined with NACT can improve tumor response in advanced ovarian cancer compared with NACT alone.
Authors
- Shanping Wang (ORCID: https://orcid.org/0000-0003-1313-369X)
- Yanying Ma
- Li Wang (ORCID: https://orcid.org/0000-0002-5595-2741)
- Lei Li (ORCID: https://orcid.org/0000-0002-4456-2983)
- Han Li (ORCID: https://orcid.org/0000-0003-0846-3846)
- Yuhua Wang (ORCID: https://orcid.org/0000-0002-8658-5411)
- Xiaojie Feng
- Zhang Ye (ORCID: https://orcid.org/0000-0003-3495-5596)
Institutions
- Guangdong University of Technology (CN)
- Guangzhou Institutes of Biomedicine and Health (CN)
- Henan Cancer Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-09-09
- DOI
- https://doi.org/10.3389/fonc.2025.1639810
- Primary Topic
- Intraperitoneal and Appendiceal Malignancies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Basic and Applied Basic Research Foundation of Guangdong Province